Pharmaceutical platforms
One publishing platform for more than 100 regulated markets.
I engineered core parts of a global pharmaceutical publishing platform where localisation, medical review, market eligibility, accessibility, and editorial speed had to coexist in one content model.
Technology
Global reuse could never override local approval
Regional teams needed to publish quickly across more than 100 markets, while medical, legal, and regulatory approval remained independently auditable for every applicable jurisdiction.
The same platform served public visitors, healthcare professionals, patients, and regulatory stakeholders with different access and content requirements.
Encoded regulation into the publishing model
I owned work across the headless content architecture, market-variant model, approval workflow, search experience, and performance and accessibility controls.
The architecture treated approval state as part of the content model rather than a process tracked outside the publishing system.
Architecture
Approval state belonged in the content model
Reusable content, jurisdictional applicability, reviewer evidence, and publication eligibility were modelled together so the correct path was enforceable by the platform.
- 01
Constraint
A simple translation model could incorrectly reuse one market's regulatory approval in another jurisdiction.
Decision
Model clinical and promotional blocks as market variants with independent applicability and approval state.
Impact
An approval in one country never silently authorises publication in another.
- 02
Constraint
Reviewers lost time switching to staging simply to understand what a content change would look like.
Decision
Provide rendered previews inside the medical-legal-regulatory workflow and route lower-risk editorial changes through a defined lighter track.
Impact
The preview removed roughly half a day from common review cycles, while more than 30% of submissions used the appropriate streamlined path.
- 03
Constraint
Pharmaceutical tables and gated content had to remain usable across keyboard and screen-reader workflows.
Decision
Test each reusable component with NVDA, JAWS, and VoiceOver before admitting it to the shared component library.
Impact
An independent launch audit verified WCAG 2.1 AA compliance without a late remediation sprint.
Outcome
Global scale without collapsing market-level governance
- The platform supported more than 100 market sites and over 30 locales.
- First-submission completion of the full approval chain reached 78% in the first quarter.
- Medicine-finder queries stayed below 400 milliseconds at p95.
- Market-specific publication and healthcare-professional gating were encoded in the platform rather than handled manually.
Regulated publishing becomes faster when the platform makes the correct path obvious. Removing ambiguity from approval state was more valuable than removing approval steps.
Abrar
Start a project
Designing a global platform with local regulatory rules?
I can help model content, approvals, access, and infrastructure as one operable system rather than disconnected governance layers.
Discuss your web platform